Moneycontrol PRO
Open App
you are here: HomeNewsPodcast

The Market Podcast | Dalal Street will bounce back, right time to accumulate ‘jewels of India’

Investors should look at buying the companies where there is a strong business model, says Shailendra Kumar.

March 27, 2020 / 07:26 PM IST

The Indian market might have given a mixed response to the measures introduced by the Reserve Bank of India (RBI) on Friday, but these are strong measures and will help India back on its feet much quicker than other global counterparts, Shailendra Kumar, CIO, Narnolia Financial Advisors, said in the ‘Market podcast’ with Moneycontrol.

The bottoming out process for Indian markets has already begun. “We turned positive on Indian markets on Tuesday and the primary reason is that FPI selling is likely to reduce now, which was the primary reason for the fall in the first place,” he said.

Most of the money which was flowing out was the ETF selling and India has a 10 percent weightage in the emerging market basket. With the introduction of the stimulus package from the US Fed, where they said they would buy corporate bond ETF, the move is likely to calm nerves of global investors, Kumar said.

Indian equities, having 10 percent weight in emerging market ETFs, suffered the collateral damage. This high selloff in such a short time span cannot get matching domestic buyers.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

This sharp fall in all the liquid investment asset classes happened as most of the corporations and investors moved towards cash (‘move to cash’ trades) to tide over the near term pain of a standstill economy.

He added that the fall is good for long-term investors because India should be able to get back on its feet in a quick time, and the time is right to accumulate jewels of India.

“History suggests that humanity has always won, and this too shall pass. No doubt the economy is in a difficult zone and we might be staring at a negative GDP growth in the next quarter. But, the long-term story remains intact and this is the time to buy the jewels of India,” Kumar added.

Investors should look at buying the companies where there is a strong business model, and management credibility is very strong.

COVID-19 is a threat to humanity and damage to the underlying economy is significant. Being the barometer, the equity market has fallen in tandem with this Black Swan event.

But the valuation compression is significant and the market has extrapolated current economic pains even for long-term earning potentials of the companies.

On a simplified basis, any price below the Nifty levels of 9,500 is an undervaluation level, though when the market is not in a normal rational state, it can show us any price but those surely would not be a long term reality.

(Tune in to the podcast for more)

Disclaimer: The views and investment tips expressed by experts on are their own and not those of the website or its management. advises users to check with certified experts before taking any investment decisions.
Kshitij Anand is the Editor Markets at Moneycontrol.
ISO 27001 - BSI Assurance Mark